Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer

[1]  Jae Young Lee,et al.  Locally advanced rectal cancer: added value of diffusion-weighted MR imaging in the evaluation of tumor response to neoadjuvant chemo- and radiation therapy. , 2009, Radiology.

[2]  G. Beets,et al.  Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? , 2009, Radiology.

[3]  Jeong Min Lee,et al.  Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer , 2009, Journal of magnetic resonance imaging : JMRI.

[4]  A. Crucitti,et al.  Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. , 2009, Radiology.

[5]  Gina Brown,et al.  MRI staging of low rectal cancer , 2009, European Radiology.

[6]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[7]  B. Choi,et al.  Diagnostic Accuracy of 3.0-Tesla Rectal Magnetic Resonance Imaging in Preoperative Local Staging of Primary Rectal Cancer , 2008, Investigative radiology.

[8]  B. Choi,et al.  Sonography transmission gel as endorectal contrast agent for tumor visualization in rectal cancer. , 2008, AJR. American journal of roentgenology.

[9]  David J Collins,et al.  Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy , 2008, Nature Clinical Practice Oncology.

[10]  A. Razek,et al.  Role of diffusion-weighted magnetic resonance imaging in differentiation between the viable and necrotic parts of head and neck tumors , 2008, Acta radiologica.

[11]  T. Junginger,et al.  Neoadjuvant Chemoradiation and Local Excision for T2-3 Rectal Cancer , 2008, Annals of Surgical Oncology.

[12]  K. Bujko,et al.  Chemoradiotherapy alone for rectal cancer: a word of caution. , 2007, The Lancet. Oncology.

[13]  B. O'neill,et al.  Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer. , 2007, The Lancet. Oncology.

[14]  C. Velde,et al.  Considerations and restrictions for non-operative treatment of rectal cancer in selected patients , 2007 .

[15]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[16]  A. Razek,et al.  Role of Diffusion-Weighted Echo-Planar MR Imaging in Differentiation of Residual or Recurrent Head and Neck Tumors and Posttreatment Changes , 2007, American Journal of Neuroradiology.

[17]  J. Guillem,et al.  A Pathologic Complete Response of Rectal Cancer to Preoperative Combined-Modality Therapy Results in Improved Oncological Outcome Compared With Those Who Achieve No Downstaging on the Basis of Preoperative Endorectal Ultrasonography , 2006, Annals of Surgical Oncology.

[18]  A R Padhani,et al.  Diffusion-weighted MRI: a new functional clinical technique for tumour imaging. , 2006, The British journal of radiology.

[19]  C. McConkey,et al.  Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. , 2005, The British journal of radiology.

[20]  Tae Hyun Kim,et al.  Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer. , 2005, International journal of radiation oncology, biology, physics.

[21]  Young Seok Kim,et al.  Phase II study of radiotherapy with three-dimensional conformal boost concurrent with paclitaxel and cisplatin for Stage IIIB non-small-cell lung cancer. , 2005, International journal of radiation oncology, biology, physics.

[22]  P. Wust,et al.  Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging? , 2005, European Radiology.

[23]  Fábio Guilherme Campos,et al.  Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation Therapy: Long-term Results , 2004, Annals of surgery.

[24]  Andrew G. Lee,et al.  Are pretreatment simulation estimates predictive of actual rectal and bladder doses delivered during radiation for prostate cancer , 2004 .

[25]  A. Chan,et al.  Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. , 2003, International journal of radiation oncology, biology, physics.

[26]  Alexander de Vries,et al.  Preliminary Results on the Influence of Chemoradiation on Apparent Diffusion Coefficients of Primary Rectal Carcinoma Measured by Magnetic Resonance Imaging , 2003, Strahlentherapie und Onkologie.

[27]  C. L. Brown,et al.  Response to Preoperative Chemoradiation in Stage II and III Rectal Cancer , 2003, Diseases of the colon and rectum.

[28]  Jürgen Griebel,et al.  Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma. , 2003, International journal of radiation oncology, biology, physics.

[29]  Jürgen Griebel,et al.  Diffusion-weighted magnetic resonance imaging for monitoring diffusion changes in rectal carcinoma during combined, preoperative chemoradiation: preliminary results of a prospective study. , 2003, European journal of radiology.

[30]  D. Rothenberger,et al.  A Pathologic Complete Response to Preoperative Chemoradiation Is Associated With Lower Local Recurrence and Improved Survival in Rectal Cancer Patients Treated by Mesorectal Excision , 2003, Diseases of the colon and rectum.

[31]  V. Valentini,et al.  Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. , 2002, International journal of radiation oncology, biology, physics.

[32]  C. Taylor,et al.  T-Level Downstaging and Complete Pathologic Response After Preoperative Chemoradiation for Advanced Rectal Cancer Result in Decreased Recurrence and Improved Disease-Free Survival , 2002, Diseases of the colon and rectum.

[33]  M. Bonnen,et al.  Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients. , 2001, International journal of radiation oncology, biology, physics.

[34]  L. Ellis,et al.  Improved Overall Survival Among Responders to Preoperative Chemoradiation for Locally Advanced Rectal Cancer , 2001, American journal of clinical oncology.

[35]  C. Compton,et al.  Colon and Rectum , 2012 .

[36]  J. Gu,et al.  Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted MR imaging for early detection of tumor histopathologic downstaging. , 2010, Radiology.

[37]  A. Makris,et al.  Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3–T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision? , 2005, International Journal of Colorectal Disease.

[38]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.

[39]  O. Dworak,et al.  Pathological features of rectal cancer after preoperative radiochemotherapy , 1997, International Journal of Colorectal Disease.

[40]  Jan Wolber,et al.  Diffusion MRI for prediction of response of rectal cancer to chemoradiation , 2002, The Lancet.